Debt & Equity Capital Markets
Structuring and placement of debt and equity financing for qualified corporate clients, coordinating across institutional investors, bank syndicates, sovereign funds, and specialist sector participants.
Institutional Capital for Private Companies
Innekto Incorporated advises on both debt and equity capital raises, connecting quality companies with appropriate institutional capital across bank syndicates, credit funds, institutional investors, sovereign wealth funds, and family offices.
We advise on transaction structure, pricing, documentation, and investor sequencing, and we manage the end-to-end placement process from investor targeting through to subscription and close.
Our track record spans multi-billion dollar debt syndications, follow-on equity offerings, and private placements across healthcare, life sciences, specialty chemicals, and adjacent sectors.
Capital Raising Process
Financial performance review, capital structure analysis, and investor positioning narrative.
Investor memorandum, financial model, management presentation, and data room construction.
Curated investor list developed, NDAs executed, and materials distributed to qualified parties.
Management presentation roadshow coordinated. Q&A, follow-up, and due diligence managed.
Term sheet negotiation, subscription documentation, and transaction close coordination.
Representative Debt Capital Raising Transactions
Joint bookrunning manager on a $21 billion multi-tranche bond issuance for a specialty pharmaceutical company, one of the largest pharmaceutical bond offerings of the year.
Joint lead arranger and bookrunner for a $5 billion permanent bank facility supporting a specialty pharmaceutical company's $66 billion strategic acquisition, providing bridge-to-permanent financing.
Joint lead arranger and bookrunner for a $7 billion bridge-to-bonds and loan facility structured to support a $28 billion pharmaceutical acquisition, coordinating across a large bank syndicate.
Lead arranger for a $14 billion bridge loan structured to support the acquisition of a major consumer health business, executed across a multi-lender syndicate with tight timeline requirements.
Joint lead arranger and bookrunner for a $6 billion term loan facility structured to fund the acquisition of an oncology company, coordinating regulatory approval conditions into the financing terms.
Lead arranger for a $1.07 billion leveraged loan supporting the private equity-backed acquisition of a pharmaceutical capsule manufacturer, structuring a financing package suited to the PE hold period.
Underwriter for a $300 million Senior Notes offering by a specialty chemicals company, providing long-term fixed-rate debt capital to support operational and strategic objectives.
Joint arranger for $7 billion of bridge, asset sale, and incremental credit facilities structured to support a major pharmaceutical merger, managing a complex multi-instrument financing across a broad syndicate.
Representative Equity Capital Raising Transactions
Joint bookrunning manager on a concurrent $7.4 billion stock and convertible note offering by a specialty pharmaceutical company — one of the largest combined equity and convertible transactions in the sector.
Underwriter on a $433 million follow-on equity offering for an oncology biopharmaceutical company, supporting clinical pipeline advancement and commercialisation activities.
Underwriter on a $138 million follow-on equity offering for an epigenetics-focused oncology company, funding continued R&D across its cancer biology pipeline.
Underwriter on a $116 million follow-on equity offering for a synthetic biology company, providing growth capital to scale manufacturing and commercial operations.
Underwriter on a $110 million follow-on equity offering for a nephrology biopharmaceutical company focused on rare kidney diseases, funding late-stage clinical development.
Underwriter on an $87 million follow-on equity offering for an oncology biopharmaceutical company, supporting advancement of its targeted therapy pipeline through clinical milestones.
Exclusive placement agent for a private placement of equity in an aquatic biomass company, coordinating capital from a Middle Eastern institutional fund to support sustainable resource development.
Joint bookrunning manager on an $80 million follow-on equity offering for a biological testing and diagnostics company, funding expansion of its laboratory services platform.
Transaction Provenance Note: Transactions listed above are representative of mandates completed by Innekto Incorporated and mandates completed by senior members of the Innekto team during the course of their careers at leading financial institutions prior to Innekto's formation. Capital market transactions, including debt syndications and equity offerings, were executed as part of institutional banking mandates at predecessor institutions and are included to illustrate the senior team's transaction depth. All transactions are presented for illustrative purposes only. Client identities and confidential transaction details are not disclosed.
Discuss a Capital Raise
Contact our team to explore debt or equity capital raising options for your organisation.
The information presented on this page is intended for institutional counterparties and professional investors only. All references to target returns, yield strategies, and projected outcomes represent forward-looking estimates subject to material market, credit, liquidity, and operational risks. Past performance is not indicative of future results. Nothing herein constitutes an offer to buy or sell securities or investment products.